Q 35

Known as: Q-35 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1996
012319921996

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The bactericidal effects of Q-35, sparfloxacin, tosufloxacin, and ofloxacin on 18 strains of methicillin-resistant Staphylococcus… (More)
Is this relevant?
1995
1995
To investigate emerging fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan, we compared the in vitro… (More)
Is this relevant?
1995
1995
Q-35, a new fluoroquinolone, was evaluated for its in vitro and in vivo antibacterial activities. In vitro antibacterial activity… (More)
Is this relevant?
1994
1994
Q-35, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3- methylaminopiperidine-1-yl)-4-oxyquinoline-3-carboxylic acid, has… (More)
Is this relevant?
1994
1994
Scalp hair samples were obtained every month for three months after administration from healthy male volunteers who participated… (More)
  • figure 1
  • figure 5
Is this relevant?
1994
1994
Some of the many antimicrobial agents (beta-lactams, macrolides, aminoglycosides, tetracyclines, new quinolones; NQs) were… (More)
Is this relevant?
1993
1993
New carboxyquinolone drugs, including the recently developed Q-35, were evaluated for their in vitro potency against five… (More)
Is this relevant?
1993
1993
The in vitro potency and in vivo efficacy of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae were investigated by… (More)
Is this relevant?
1993
1993
A newly developed fluoroquinoline, Q-35 (8-OCH3), in which a methoxy group was substituted at the 8 position of the quinoline… (More)
Is this relevant?
1992
1992
The in vitro activity of Q-35, an 8-methoxy fluoroquinolone, was compared with those of ofloxacin, ciprofloxacin, tosufloxacin… (More)
Is this relevant?